“Implanet will be 100 percent devoted to the treatment of spinal disorders,” CEO Ludovic Lastennet said.
The company aims to use the funds to accelerate the growth of its spine business, which includes its Jazz portfolio for the treatment of degenerative spine disorders requiring fusion.
Selling the knee system will provide Implanet with funding for growth initiatives, including potential acquisitions in the spine field.
The company did not reveal who the potential buyers were for its knee system.
More articles on devices:
28.4M elective surgeries could be canceled in 2020 — orthopedic procedures hit hardest
Research finds lowest average cost of hip, knee replacements at 3 New York City hospitals
Texas orthopedic group snares 2 paycheck protection program loans
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
